Shandong Buchang Pharmaceuticals (603858.SH) donated medicines and cash totaling 37.6621 million yuan.
Stride Pharmaceutical (603858.SH) announced that recently, the company and its wholly-owned subsidiary Shandong Stride Pharmaceutical Sales Co., Ltd...
Shandong Buchang Pharmaceuticals (603858.SH) announced that recently, the company and its wholly-owned subsidiary Shandong Buchang Pharmaceutical Sales Co., Ltd., and its holding subsidiary Liaoning Aoda Pharmaceutical Co., Ltd. signed donation agreements with relevant public welfare organizations, donating a total of 37.6621 million yuan in medicines and cash for conducting public welfare activities.
In addition to this donation, from the date of the last disclosure of external donations (July 4, 2024) to the date of this announcement, the company and its holding subsidiary have cumulatively donated 3.8045 million yuan, including 318,100 yuan in donated medicines and 3.4864 million yuan in cash, mainly donated to public welfare organizations such as the Beijing Tongxin Gongzhu Public Welfare Foundation, the Beijing Union Medical College Foundation, the China Elderly Health Care Association, and the Beijing Liver and Gallbladder Care Public Welfare Fund for public welfare activities.
Related Articles
HK Stock Market Move | In the near future, the internal housing stocks continued to decline. Institutions pointed out that policy expectations were not met and the potential for a small rebound in the market was lacking. The performance of the real estate sector was relatively weak.
Nomura: Raised NONGFU SPRING (09633) target price to HK$50.5, maintaining a "hold" rating.
Guosen: In the future, the passenger volume and fleet of the aviation industry will double. We will focus on developing domestic alternatives and autonomous control.
HK Stock Market Move | In the near future, the internal housing stocks continued to decline. Institutions pointed out that policy expectations were not met and the potential for a small rebound in the market was lacking. The performance of the real estate sector was relatively weak.
Nomura: Raised NONGFU SPRING (09633) target price to HK$50.5, maintaining a "hold" rating.
Guosen: In the future, the passenger volume and fleet of the aviation industry will double. We will focus on developing domestic alternatives and autonomous control.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
